Comparison of Electroacupuncture and Mild-Warm Moxibustion on Brain-Gut Function in Patients with Constipation-Predominant Irritable Bowel Syndrome: A Randomized Controlled Trial

被引:30
|
作者
Zhao Ji-meng [1 ]
Lu Jin-hua [2 ]
Yin Xiao-jun [1 ]
Wu Lu-yi [1 ]
Bao Chun-hui [1 ]
Chen Xing-kui [3 ]
Chen Yue-hua [4 ]
Tang Wei-jun [5 ]
Jin Xiao-ming [6 ]
Wu Huan-gan [1 ]
Shi Yin [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shanghai Res Inst Acupuncture Moxibust & Meridian, Shanghai 200030, Peoples R China
[2] Jinhua Municipal Cent Hosp, Med Imaging Dept, Jinhua 321000, Zhejiang, Peoples R China
[3] Jinhua Municipal Cent Hosp, Dept Acupuncture & Moxibust, Jinhua 321000, Zhejiang, Peoples R China
[4] Jinhua Municipal Cent Hosp, Dept Digest Syst, Jinhua 321000, Zhejiang, Peoples R China
[5] Fudan Univ, Huashan Hosp, Radiol Dept, Shanghai 200040, Peoples R China
[6] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA
基金
中国国家自然科学基金;
关键词
irritable bowel syndrome; constipation; electroacupuncture; moxibustion; randomized controlled trial; VISCERAL HYPERSENSITIVITY; HEALTHY-VOLUNTEERS; FMRI; DISORDERS; RESPONSES; STIMULI; SCALE; PAIN; IBS; METAANALYSIS;
D O I
10.1007/s11655-018-2838-0
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective: To compare the effects of electroacupuncture (EA) and mild-warm moxibustion (Mox) therapies for constipation-predominant irritable bowel syndrome (C-IBS) patients. Methods: Sixty C-IBS patients were assigned to 2 groups by simple randomized method, i.e. EA group (30 cases) and Mox group (30 cases). Both EA and Mox treatments were performed on bilateral Tianshu (ST 25) and Shangjuxu (ST 37) for 30 min each time, 6 times per week, for 4 consecutive weeks. The gastrointestinal symptoms and psychological symptoms of the two groups were scored before and after treatment. The effects on the corresponding functional brain areas, namely the anterior cingulate cortex (ACC), insular cortex (IC) and prefrontal cortex (PFC) were observed by functional magnetic resonance imaging (fMRI) before and after treatment. Results: Compared with the Mox group, greater improvements in abdominal distension, defecation frequency, difficulty in defecation and stool features were observed in the EA group (all P < 0.01), both Hamilton Anxiety Rating Scale and Hamilton Depression Rating Scale scores were significantly decreased in the EA group (all P < 0.01). Finally, decreased activated voxel values were observed in the ACC, right IC and PFC brain regions of EA group with 150 mL colorectal distension stimulation (P < 0.05 or P < 0.01). Conclusions: Both EA and Mox could significantly improve some of the most intrusive symptoms of C-IBS patients, and EA was more effective than Mox. The therapeutic effect of these two therapies might through modulating of the brain-gut axis function.
引用
收藏
页码:328 / 335
页数:8
相关论文
共 42 条
  • [31] Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial
    Wang, Yan
    Huang, Yong-quan
    Zhu, Shui-lian
    Zhang, Chang-rong
    Chen, Xin-lin
    Hou, Qiu-ke
    Liu, Feng-bin
    TRIALS, 2020, 21 (01)
  • [32] Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub-cohort analysis of a phase III, randomized, double-blind, placebo-controlled trial
    Peng, Li Hua
    Fang, Jing Yuan
    Dai, Ning
    Shen, Xi Zhong
    Yang, You Lin
    Sun, Jing
    Yang, Yun Sheng
    JOURNAL OF DIGESTIVE DISEASES, 2022, 23 (02) : 99 - 110
  • [33] Efficacy and Safety of Traditional Chinese Patent Medicine Qizhi Weitong Granules(气滞胃痛颗粒) in Irritable Bowel Syndrome with Predominant Constipation:A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials
    曹增
    陶紫晶
    蒋天媛
    刘倩
    牛然
    张格知
    杨洋
    魏玮
    WorldJournalofIntegratedTraditionalandWesternMedicine, 2023, 9 (04) : 13 - 20
  • [34] Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial
    Shin, Seung Yong
    Park, Sein
    Moon, Jung Min
    Kim, Kisung
    Kim, Jeong Wook
    Chun, Jongsik
    Lee, Tae Hee
    Choi, Chang Hwan
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 28 (04) : 642 - 654
  • [35] Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial
    Zahedi, Mohammad Javad
    Behrouz, Vahideh
    Azimi, Maryam
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (06) : 1192 - 1199
  • [36] Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial
    Yan Wang
    Yong-quan Huang
    Shui-lian Zhu
    Chang-rong Zhang
    Xin-lin Chen
    Qiu-ke Hou
    Feng-bin Liu
    Trials, 21
  • [37] Comparison of the Effect of Dialectical Behavior Therapy, Mindfulness Based Cognitive Therapy and Positive Psychotherapy on Perceived Stress and Quality of Life in Patients with Irritable Bowel Syndrome: a Pilot Randomized Controlled Trial
    Javad Mohamadi
    Firoozeh Ghazanfari
    Fazlollah Mir Drikvand
    Psychiatric Quarterly, 2019, 90 : 565 - 578
  • [38] Comparison of the Effect of Dialectical Behavior Therapy, Mindfulness Based Cognitive Therapy and Positive Psychotherapy on Perceived Stress and Quality of Life in Patients with Irritable Bowel Syndrome: a Pilot Randomized Controlled Trial
    Mohamadi, Javad
    Ghazanfari, Firoozeh
    Drikvand, Fazlollah Mir
    PSYCHIATRIC QUARTERLY, 2019, 90 (03) : 565 - 578
  • [39] Effects of Spirulina (Arthrospira) platensis supplementation on intestinal permeability, antioxidant and inflammatory markers, quality of life and disease severity in patients with constipated-predominant irritable bowel syndrome: a randomized double‑blind, placebo‑controlled trial
    Saeede Jafari Nasab
    Awat Feizi
    Parisa Hajihashemi
    Mohammad-Hassan Entezari
    Manoj Sharma
    Peyman Adibi
    Mohammad Bagherniya
    Nutrition Journal, 24 (1)
  • [40] Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    Tomita, Toshihiko
    Fukui, Hirokazu
    Morishita, Daisuke
    Mori, Sumire
    Oshima, Tadayuki
    Shinzaki, Shinichiro
    Miwa, Hiroto
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)